about
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer CompoundsMeasuring microRNA expression levels in oncology: from samples to data analysis.Accurate data processing improves the reliability of Affymetrix gene expression profiles from FFPE samplesProposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation.Reciprocal regulation of p63 by C/EBP delta in human keratinocytes.A transcriptional sketch of a primary human breast cancer by 454 deep sequencingIntersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers.Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells.AF1q: a novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells.Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues.Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosaBy promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy.Use of formalin-fixed paraffin-embedded samples for gene expression studies in breast cancer patientsmiR-30e* is an independent subtype-specific prognostic marker in breast cancerMolecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype.Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activationIn-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarraysmiR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts.Bioinformatics tools for secretome analysis.Feasibility of circulating miRNA microarray analysis from archival plasma samples.Gene expression profiling of circulating tumor cells in breast cancer.Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types.miR-21: an oncomir on strike in prostate cancer.Challenges in using circulating miRNAs as cancer biomarkers.Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer.Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.MicroRNA detection in plasma samples: how to treat heparinized plasma.Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts.Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer.Circulating Biomarkers for Prediction of Treatment Response.Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer.Predicting and Understanding Cancer Response to Treatment.PATRI, a Genomics Data Integration Tool for Biomarker DiscoveryA lipemia-independent NanoDrop®-based score to identify hemolysis in plasma and serum samples
P50
Q28598343-0983D1DD-340D-449E-9C5A-2DC1434DED02Q30619741-2798EF21-0470-4F0F-B967-77A6B2E98815Q30747169-53B5A3CE-B371-42C7-99C2-617133E7896EQ31025891-F301CF4A-DB70-4D58-BAC1-DFF5282130C0Q33300780-D13154DB-D1A8-40C3-9E2C-3640E4BFC010Q33432300-EEF2F91D-CD0B-4DAC-9B9A-0D7AF740BC15Q33572945-39C6582F-A186-401C-ABB2-9C5937C3208DQ33617345-5805CA5D-08BA-4835-9583-925EE0F253DBQ34326688-1538274D-E07E-4DBA-A17A-01C8610B1E08Q34428112-12494C69-55A0-4C33-AC7F-08409235D0DCQ34545033-2BF1A086-C37A-49EC-8264-53753C4D8E7BQ35273614-148BDEE5-249E-4562-91D0-7412515EC96CQ35284791-4089C522-D13C-4A94-814B-500FAE2DA89AQ35863168-E0B34EC3-5E96-4F8A-8B76-4FEE1D6A0825Q35928897-F40901F3-8D93-4AE7-AF81-BA85D41B3F64Q36544603-9B0F81AE-AAEA-4804-9DC9-4F518B03BDF2Q36729581-8EB4A2C5-36CA-4033-8C96-C5963CC97695Q37593531-6AD990AF-05D1-427B-B2FA-A203AF47E9D1Q38080348-2721108C-D04C-4CFD-8757-9BE278A66E57Q38397745-FFDFEBE9-1023-44C3-918F-41E7715CD0DCQ38470332-B1869D6B-B9B7-4BFA-8ADA-6F430EC62818Q38576565-DD71858A-9070-4BA5-BA2F-416EDFE74681Q39749407-B6348E92-1BD2-427A-B953-F0B7D853C945Q41072824-C7BAB06D-8AE6-4C68-BCE9-B50BDC619234Q41135122-BBB1CA76-046F-41FD-855F-AD7FDAA3E680Q41880628-09A496E2-ECFA-4973-BF5E-3359C3906ABCQ43455808-96FB6C07-2763-45F6-ABF7-570EE436E9C3Q45333964-C1331568-F20F-4805-9699-FC2F137E488EQ47204651-98B91D60-A2E6-42F0-847D-05FA4018A4FDQ48284400-C1F14C5B-0C35-476E-827A-EC695ADD065DQ53471686-F74785CD-4D7C-4A9C-97E3-E8A3B336B1FBQ55041652-D80D4C9F-D06A-4A68-9D6A-BF4CEE39391EQ55554986-B5F49816-D320-4C79-A426-4F68E50AD861Q58883545-0072624D-98D7-430A-8883-AB84F8658FDAQ59340388-056405A9-6FD2-4B84-A0CC-290A7C1860DF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maurizio Callari
@ast
Maurizio Callari
@en
Maurizio Callari
@es
Maurizio Callari
@nl
Maurizio Callari
@sl
type
label
Maurizio Callari
@ast
Maurizio Callari
@en
Maurizio Callari
@es
Maurizio Callari
@nl
Maurizio Callari
@sl
prefLabel
Maurizio Callari
@ast
Maurizio Callari
@en
Maurizio Callari
@es
Maurizio Callari
@nl
Maurizio Callari
@sl
P106
P1153
26535428900
P21
P31
P496
0000-0001-5239-0918
P569
2000-01-01T00:00:00Z